Physiologically active polypeptide conjugate having prolonged in vivo half-life
Details for Australian Patent Application No. 2004220163 (hide)
International Classifications
Event Publications
29 September 2005 PCT application entered the National Phase
PCT publication WO2004/081053 Priority application(s): WO2004/081053
31 January 2008 Application Accepted
Published as AU-B-2004220163
29 May 2008 Standard Patent Sealed
27 January 2011 Assignment Registered
Hanmi Pharm. Co. Ltd. The patent has been assigned to Hanmi Holdings Co., Ltd.
30 August 2012 Application for Amendment
The nature of the amendment is: Amend Patentee to read Hanmi Science Co., Ltd. . Address for service in Australia - Cullens Patent and Trade Mark Attorneys Level 32 239 George Street Brisbane QLD 4000
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004220169-salue extraction from harvested trees and related laminates and processes
2004220156-Monoclonal antibody and hybridoma producing the same
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser